The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors

Journal of Pineal Research

Volumn 39, Issue 2, 2005, Pages 170-177

  Sumaya, I C ^a,b   Masana, M I ^a   Dubocovich, Margarita L ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antidepressant effect; C3H HeN mice; Forced swimming test; Luzindole; MT 1 and MT2 knockout mice; MT1 and MT2 melatonin receptors

Indexed keywords

LUZINDOLE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; FORCED SWIMMING TEST; GENE DELETION; GENE DISRUPTION; IMMOBILIZATION; MALE; MOTOR COORDINATION; MUSCLE STRENGTH; NONHUMAN;

ANIMALS; ANTIDEPRESSIVE AGENTS; LIGANDS; MELATONIN; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; SWIMMING; TRYPTAMINES;

EID: 23744503399     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2005.00233.x     Document Type: Article

References (39)

1. ARENDT J. Melatonin. Clin Endocrinol (Oxf) 1988; 29:205-229.
2. CAJOCHEN C, KRAUCHI K, WIRZ-JUSTICE A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 2003; 15:432-437.
3. DUBOCOVICH ML, BENLOUCIF S, MASANA MI. Melatonin receptors in the mammalian suprachiasmatic nucleus. Behav Brain Res 1996; 73:141-147.
4. DUBOCOVICH ML, RIVERA-BERMUDEZ MA, GERDIN MJ et al. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 2003; 8:d1093-d1108.
5. SKENE DJ. Optimization of light and melatonin to phase-shift human circadian rhythms. J Neuroendocrinol 2003; 15:438-441.
6. GUERIN MV, DEED JR, MATTHEWS CD. The coincidence of light and melatonin with a specific phase of the circadian pacemaker is important for the timing of seasonal breeding in the ewe. J Biol Rhythms 2000; 15:514-523.
7. MALPAUX B, MIGAUD M, TRICOIRE H et al. Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. J Biol Rhythms 2001; 16:336-347.
8. PACCHIEROTTI C, IAPICHINO S, BOSSINI L et al. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol 2001; 22:18-32.
9. TUUNAINEN A, KRIPKE DF, ELLIOTT JA et al. Depression and endogenous melatonin in postmenopausal women. J Affect Disord 2002; 69:149-158.
10. FOUNTOULAKIS KN, KARAMOUZIS M, IACOVIDES A et al. Morning and evening plasma melatonin and dexamethasone suppression test in patients with nonseasonal major depressive disorder from northern Greece (latitude 40-41.5 degrees). Neuropsychobiology 2001; 44:113-117.
11. PAPARRIGOPOULOS T. Melatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depression. Acta Psychiatr Scand 2002; 106:440-445.
12. WETTERBERG L, APERIA B, GORELICK DA et al. Age, alcoholism and depression are associated with low levels of urinary melatonin. J Psychiatry Neurosci 1992; 17:215-224.
13. VARMA A, KAUL RK, VARMA P et al. The effect of antidepressants on serum melatonin levels in endogenous depression. J Assoc Physicians India 2002; 50:1262-1265.
14. RABE-JABLONSKA J, SZYMANSKA A. Diurnal profile of melatonin secretion in the acute phase of major depression and in remission. Med Sci Monit 2001; 7:946-952.
15. SZYMANSKA A, RABE-JABLONSKA J, KARASEK M. Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and anti-depressant treatment. Neuroendocrinol Lett 2001; 22:192-198.
16. PORSOLT RD, BERTIN A, JALFRE M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229:327-336.
17. SHAJI AV, KULKARNI SK. Central nervous system depressant activities of melatonin in rats and mice. Ind J Exp Biol 1998; 36:257-263.
18. RAGHAVENDRA V, KAUR G, KULKARNI SK. Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur Neuropsychopharmacol 2000; 10:473-481.
19. HILL MN, BROTTO LA, LEE TT et al. Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:905-911.
20. BOURIN M, MOCAER E, PORSOLT R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 2004; 29:126-133.
21. DUBOCOVICH ML, MOGILNICKA E, ARESO P. Antidepressant-like activity of the melatonin receptor antagonist luzindole (N-0774) in the mouse behavioral despair test. Eur J Pharmacol 1990; 182:313-325.
22. OVERSTREET DH, PUCILOWSKI O, RETTON MC et al. Effects of melatonin receptor ligands on swim test immobility. Neuroreport 1998; 9:249-253.
23. BRUTTO LA, BARR AM, GORZALKA BB. Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol 2000; 402: 87-93.
24. 1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 1997; 355:365-375.
25. DUBOCOVICH ML, YUN K, AL-GHOUL WM et al. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 1998; 12:1211-1220.
26. LIU C, WEAVER DR, JIN X et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19:91-102.
27. JIN X, VON GALL C, PIESCHL RL et al. Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003; 23:1054-1060.
28. PITTLER SJ, BAEHR W. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci U S A 1991; 88:8322-8326.
29. VAUGHAN GM. New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response. J Pineal Res 1993; 15:88-103.
30. MASANA MI, BENLOUCIF S, DUBOCOVICH ML. Circadian rhythm of mt1 melatonin receptor expression in the suprachi-asmatic nucleus of the C3H/HeN mouse. J Pineal Res 2000; 28:185-192.
31. VIVIEN-ROELS B, MALAN A, RETTORI MC et al. Daily variations in pineal melatonin concentrations in inbred and outbred mice. J Biol Rhythms 1998; 13:403-409.
32. VON GALL C, LEWY A, SCHOMERUS C et al. Transcription factor dynamics and neuroendocrine signalling in the mouse pineal gland: a comparative analysis of melatonin-deficient C57BL mice and melatonin-proficient C3H mice. Eur J Neurosci 2000; 12:964-972.
33. WU WT, REITER RJ, TROIANI ME et al. Elevated daytime rat pineal and serum melatonin levels induced by isoproterenol are depressed by swimming. Life Sci 1987; 41:1473-1479.
34. YAGA K, TAN DX, REITER RJ et al. Unusual responses of nocturnal pineal melatonin synthesis and secretion to swimming: attempts to define mechanisms. J Pineal Res 1993; 14:98-103.
35. TROIANI ME, REITER RJ, TANNENBAUM MG et al. Neither the pituitary gland nor the sympathetic nervous system is responsible for eliciting the large drop in elevated rat pineal melatonin levels due to swimming. J Neural Transm 1988; 74:149-160.
36. TENN C, NILES LP. Physiological regulation of melatonin receptors in rat suprachiasmatic nuclei: diurnal rhythmicity and effects of stress. Mol Cell Endocrinol 1993; 98:43-48.
37. 2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol 2001; 280:C110-C118.
38. 2 melatonin receptors. J Pharmacol Exp Ther 2003; 304:931-939.
39. 2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin. FASEB J 2004; 18:1646-1656.